Literature DB >> 2675401

Propagation of alloreactive lymphocytes from histologically negative endomyocardial biopsies from heart transplant patients. Association with subsequent histological evidence of allograft rejection.

T Weber1, T Zerbe, C Kaufman, A Zeevi, R Kormos, R Hardesty, B Griffith, R J Duquesnoy.   

Abstract

Endomyocardial biopsies from heart transplant patients were cultured in vitro in the presence of Interleukin-2 and irradiated feeder cells to propagate graft-infiltrating lymphocytes. A correlation was seen between the frequency of lymphocyte growth and the degree of cellular infiltration of the biopsies. In this study, 43 of 113 (38%) histologically negative biopsies obtained from 55 patients during the first month post-transplant yielded lymphocyte cultures. The cumulative incidence of subsequent histological rejection was considerably higher in patients with such "grower" biopsies than in patients with "nongrower" biopsies. In the grower group, we were able to obtain data on alloreactivity of 32 lymphocyte cultures assayed by primed lymphocyte testing (PLT). The presence of donor-specific PLT reactivity in the cultured lymphocytes was associated with an additional risk for subsequent histological rejection. These findings suggest that the in vitro culturing of histologically negative endomyocardial biopsies will identify patients at increased risk for developing heart transplant rejection.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2675401     DOI: 10.1097/00007890-198909000-00016

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  2 in total

Review 1.  In vitro assessment of FK 506 immunosuppressive activity in transplant patients.

Authors:  A Zeevi; R Venkataramanan; V Warty; G Eiras; M Woan; K Abu-Elmagd; M Alessiani; A Jain; A J Demetris; T Zerbe
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

2.  A clinical trial combining donor bone marrow infusion and heart transplantation: intermediate-term results.

Authors:  S M Pham; A S Rao; A Zeevi; R L Kormos; K R McCurry; B G Hattler; J J Fung; T E Starzl; B P Griffith
Journal:  J Thorac Cardiovasc Surg       Date:  2000-04       Impact factor: 5.209

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.